Evidence map›Paper›PMID 22065762›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2011

Niemann-Pick type C 1 function requires lumenal domain residues that mediate cholesterol-dependent NPC2 binding.

Maika S Deffieu, Suzanne R Pfeffer

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 94 papers.

0numbers the graph read from it
0cells of the map it votes in
94citing papers in PubMed
7.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

94 citing papers in PubMed, 157 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Unifying biology of neurodegeneration in lysosomal storage diseases.Journal of inherited metabolic disease · 2025
    Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Purification and structure of luminal domain C of human Niemann-Pick C1 protein.Acta crystallographica. Section F, Structural biology communications · 2023
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Pathways and Mechanisms of Cellular Cholesterol Efflux-Insight From Imaging.Frontiers in cell and developmental biology · 2022
    Review
  18. Article
  19. Modeling Brain Pathology of Niemann-Pick Disease Type C Using Patient-Derived Neurons.Movement disorders : official journal of the Movement Disorder Society · 2021
    Article
  20. Article

34 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Maika S DeffieuDepartment of Biochemistry, Stanford University School of Medicine, Stanford, CA 94305-5307, USA.
Suzanne R Pfeffer
Stanford University · USThe University of Texas Southwestern Medical Center · US

Funding

INTRACELLULAR TRANSPORT--THE MANNOSE/PHOSPHATE RECEPTORR01DK037332 · NIDDK · STANFORD UNIVERSITY · PI PFEFFER, SUZANNE R · 1986 to 2019
$4.7M
INTRACELLULAR TRANSPORT--THE MANNOSE-PHOSPHATE RECEPTORR37DK037332 · NIDDK · STANFORD UNIVERSITY · PI PFEFFER, SUZANNE R · 1999 to 2008
$3.4M
Intracellular Transport-The Mannose Phosphate ReceptorR56DK037332 · NIDDK · STANFORD UNIVERSITY · PI PFEFFER, SUZANNE R · 2014 to 2014
$120k
NIDDK NIH HHS DK37332NIDDK NIH HHS R01 DK037332NIDDK NIH HHS R37 DK037332NIDDK NIH HHS R56 DK037332
6 · The paper itself

Abstract

Niemann-Pick type C1 (NPC1) protein is needed for cellular utilization of low-density lipoprotein-derived cholesterol that has been delivered to lysosomes. The protein has 13 transmembrane domains, three large lumenal domains, and a cytoplasmic tail. NPC1's lumenally oriented, N-terminal domain binds cholesterol and has been proposed to receive cholesterol from NPC2 protein as part of the process by which cholesterol is exported from lysosomes into the cytosol. Using surface plasmon resonance and affinity chromatography, we show here that the second lumenal domain of NPC1 binds directly to NPC2 protein. For these experiments, a soluble NPC1 lumenal domain 2 was engineered by replacing adjacent transmembrane domains with antiparallel coiled-coil sequences. Interaction of NPC2 with NPC1 lumenal domain 2 is only detected at acidic pH, conditions that are optimal for cholesterol binding to NPC2 and transfer to NPC1; the pH is also appropriate for the acidic environment where binding would take place. Binding to NPC1 domain 2 requires the presence of cholesterol on NPC2 protein, a finding that supports directional transfer of cholesterol from NPC2 onto NPC1's N-terminal domain. Finally, human disease-causing mutations in NPC1 domain 2 decrease NPC2 binding, suggesting that NPC2 binding is necessary for NPC1 function in humans. These data support a model in which NPC1 domain 2 holds NPC2 in position to facilitate directional cholesterol transfer from NPC2 onto NPC1 protein for export from lysosomes.

Indexed as

Carrier ProteinsCell LineCholesterol, LDLElectrophoresis, Polyacrylamide GelGlycoproteinsHumansImmunoblottingIntracellular Signaling Peptides and ProteinsLysosomesMembrane GlycoproteinsModels, BiologicalNiemann-Pick C1 ProteinPlasmidsProtein BindingProtein Structure, TertiarySurface Plasmon ResonanceCarrier ProteinsCholesterol, LDLGlycoproteinsIntracellular Signaling Peptides and ProteinsMembrane GlycoproteinsNiemann-Pick C1 ProteinNPC1 protein, humanNPC2 protein, humanVesicular Transport Proteins

Identifiers

PMID22065762
PMCPMC3223457
OpenAlexW2150206832

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.